Should I Buy MASI? MASI 2026 Analysis

Should You Buy Masimo Corp (MASI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

136.250

1 Day change

-1.03%

52 Week Range

194.880

Analysis Updated At

2026/01/30

MASI is not a good buy right now for an impatient investor. The near-term technical setup is weakening (bearish MACD expansion, price sitting near key support), while options are pricing elevated uncertainty. Despite upbeat long-term analyst commentary after Investor Day, the stock lacks a clear near-term upside trigger and recent quarterly profitability deteriorated sharply. I would hold/avoid new entry at current levels and only consider buying on a clear rebound back above ~$142 with improving momentum.

Technical Analysis

Price/Trend: MASI closed at 135.89 (-1.03% regular session), sitting just under the S1 support area (S1 ~136.73) and above S2 (~133.64). The pivot is much higher at ~141.74, implying the stock is currently trading below the central pivot and is in a weaker near-term posture. Momentum: MACD histogram is negative (-0.0313) and negatively expanding, which typically signals downside momentum is building rather than stabilizing. RSI: RSI(6) ~36.3, leaning toward oversold but not showing a strong reversal signal yet. Moving averages: Converging MAs suggest consolidation/indecision, but with MACD weakening and price below pivot, the balance favors caution. Levels to watch: Support ~133.6 then ~136.7; resistance/pivot ~141.7, then ~146.8. **Intellectia Proprietary Trading Signals** - [AI Stock Picker](module://ai_stock_pick): no signal on given stock today. - [SwingMax](module://swingmax): No signal on given stock recently.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Positioning/Sentiment: Both open interest P/C (0.41) and volume P/C (0.29) are call-heavy, which is generally bullish sentiment. Volatility: Implied vol (30d) is very high (~77.29) versus historical vol (~30.52), indicating the options market is pricing elevated uncertainty and/or a potential catalyst. This can accompany breakouts, but it also means the market is not confident about direction and is demanding a big premium for protection/leverage. Activity: Today’s option volume (22) is modest, but volume vs 30-day average is high (27.16x) and open interest vs average is elevated (130.16x), suggesting a spike in attention/positioning even if absolute contracts are small. Net read: Options lean bullish (calls dominate), but the very elevated IV signals the market expects larger moves and is not “comfortable” with the current setup—this aligns with a cautious stance until price action confirms a rebound.

Technical Summary

Sell

Buy

Positive Catalysts

on 2026-02-23 after hours (EPS est. 1.54). A strong print/guidance could act as an upside catalyst.

Neutral/Negative Catalysts

with a negatively expanding MACD increases the odds of continued drift toward lower supports (~133.6).

Financial Performance

Latest quarter: 2025/Q3. Growth: Revenue rose to $371.5M (+8.21% YoY), indicating the top line is still growing. Margins: Gross margin improved slightly to 62.07% (+0.47 YoY), a modest positive. Profitability: Net income fell to -$100.4M (-1124.49% YoY) and EPS to -$1.86 (-1133.33% YoY), a major deterioration. The combination of growing revenue but sharply negative earnings points to elevated costs/one-offs or operating pressure—this is a near-term overhang until normalized profitability is demonstrated.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend: Analysts have been incrementally more constructive. Wells Fargo reiterated Overweight and raised PT to $190 (from $187) after Investor Day; BTIG kept Buy and raised PT to $200 (from $198). A newer voice, BofA, initiated at Neutral with a $162 PT. Street pros (bull case): Confidence in multi-year growth trajectory, product innovation investment, and a path to sustained high-single-digit growth. Street cons (cautious case): Not all analysts are fully bullish (Neutral initiation), and the market will likely demand proof that growth translates into stable profitability given the latest quarter’s sharp loss. Net: Wall Street is broadly positive on the longer-term story, but the near-term trade still needs technical confirmation and improved earnings quality.

6 Analyst Rating

Wall Street analysts forecast MASI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MASI is 188.4 USD with a low forecast of 162 USD and a high forecast of 210 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

4 Buy

2 Hold

0 Sell

Moderate Buy

Current: 137.670

Low

162

Averages

188.4

High

210

Current: 137.670

Low

162

Averages

188.4

High

210

Wells Fargo

Overweight

maintain

$187 -> $190

AI Analysis

2025-12-05

Reason

Wells Fargo

Price Target

$187 -> $190

AI Analysis

2025-12-05

maintain

Overweight

Reason

Wells Fargo raised the firm's price target on Masimo to $190 from $187 and keeps an Overweight rating on the shares. The firm says the company's Investor Day highlighted confidence in multi-year growth trajectory. Wells also notes that 7%-10% revenue CAGR through 2028, with new products is expected to drive double digits growth post-2028.

BTIG

Buy

maintain

$198 -> $200

2025-12-04

Reason

BTIG

Price Target

$198 -> $200

2025-12-04

maintain

Buy

Reason

BTIG raised the firm's price target on Masimo to $200 from $198 and keeps a Buy rating on the shares after the company's Investor Day presentation. The firm is positive on the company's potential to be one of the most consistent performers in MedTech over the coming years, the analyst tells investors in a research note. BTIG adds that it likes that the company will continue to invest in next-gen sensors and monitors in a market that has seen minimal product innovation from competitors and believes it will allow the company to achieve sustainable high single digit growth during and beyond the Long Range Plan.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for MASI

Unlock Now

MASI Should I Buy

MASI Should I Buy

Should You Buy Masimo Corp (MASI) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch